Artes Medical recently announced that the FDA has approved its product ArteFill as the first nonresorbable injectable filler to correct nasolabial fold rhytides. ArteFill is the first product that is a permanent support structure for continuing correction of these rhytides. FDA approval is based on ...
Obinutuzumab (Gazyva) plus bendamustine, followed by obinutuzumab alone has been approved by the FDA as a treatment of patients with follicular lymphoma who were not responsive to a rituximab regimen, or who relapsed after rituximab-based therapy.
Note:The price of each vial of Kisunla is $695.65. The total cost of Kisunla will vary by patient based on when they complete treatment. The FDA's dosing instructions state that prescribers can consider stopping the dosing of Kisunla based...
The generic liraglutide option for Victoza was approved by the FDA on December 23, 2024. The generic is only approved to be used to improve blood sugar control in type 2 diabetes (as an adjunct to diet and exercise), but it may also lead to some weight loss....
Among the FDA-approved drugs, Pegasys and Neulasta, exceeded $5 billion in 2011. It's worth mentioning that all of the FDA-approved drugs contain methoxypoly (ethylene glycol) or mPEG. The list of PEGylated drugs approved by the FDA is shown below. List of PEGylated drugs approved by ...
Bendamustine has been approved by the FDA for the treatment of CLLRecent Videos Pharmacists Can Act as Navigators for Patients Using Digital Health Tools Pharmacists Will Play Key Role in Integration of Precision Medicine Benefits of Incorporating Biosimilars Into Health System Formularies Important ...
The Salmon Is the United States’ First Genetically Engineered Animal Approved by the FDA—but There May Be More to Come This approval is the first of its kind in the United States, but other genetically modified animals may follow. The FDAis currently reviewinggenetical...
Scientists have found that verteporfin, a drug already approved by the FDA for eye disease, stopped the replication of SARS-CoV-2, the virus that causes COVID-19. An interdisciplinary research team led by the University of California, Los Angeles (UCLA) discovered that a drug already approved...
The specificity of mAbs allows the chemotherapy agents to be selectively delivered to targeted cancer cells, thereby reducing toxicity. Importantly, mAbs such as trastuzumab not only show specificity but also have anticancer effects. To date, seven ADCs have been approved by the FDA for clinical ...
The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for sale. It's the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills for preventing migraines are bein...